Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens.


  1. Home


  2. Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens.


  3. Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens.

Hansen RN, Ramsey SD, Lalla D, Masaquel A, Kamath T, Brammer M, Hurvitz SA, Sullivan SD. Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens. Springerplus. 2014 May 21;3:259. doi: 10.1186/2193-18

Upcoming Events

Full Calendar


News Categories